N-acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo

Neuroscience Letters

Volumn 236, Issue 2, 1997, Pages 91-94

  Orlando, Lianna R ^a,b   Luthi Carter, Ruth ^b   Standaert, David G ^b   Coyle, Joseph T ^a,b   Penney Jr , John B ^a,b   Young, Anne B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Excitotoxicity; Metabotropic glutamate receptors; N Methyl D aspartate receptors; N Acetylaspartylglutamate; Quinolinic acid; Striatum

Indexed keywords

EXCITOTOXIN; GLUTAMIC ACID; METABOTROPIC RECEPTOR; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; HUNTINGTON CHOREA; MALE; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

EID: 0030698798     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00769-6     Document Type: Article

References (24)

1. Ambrosini A., Bresciani L., Fracchia S., Brunello N., Racagni G. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol. Pharmacol. 47:1995;1057-1064.
2. Beal M.F., Finn S.F., Brouillet E. Evidence for the involvement of metabotropic glutamate receptors in striatal excitotoxin lesions in vivo. Neurodegeneration. 2:1993;81-91.
3. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
4. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
5. Blakely R., Coyle J. The neurobiology of N-acetylaspartylglutamate. Int. Rev. Neurobiol. 30:1988;39-100.
6. Bruno V., Battaglia G., Copani A., Giffard R.G., Raciti G., Raffaele R., Shinozaki H., Nicoletti F. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration. Eur. J. Neurosci. 7:1995;1906-1913.
7. Buisson A., Choi D.W. The inhibitory mGluR agonist, S-4-carboxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology. 34:1995;1081-1087.
8. Burlina A.P., Skaper S.D., Mazza M.R., Ferrari V., Leon A., Burlina A.B. N-Acetylaspartylglutamate selectively inhibits neuronal responses to N-methyl-D-aspartic acid in vitro. J. Neurochem. 63:1994;1174-1177.
9. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
10. Grunze H.C.R., Rainnie D.G., Hasselmo M.E., Barkai E., Hearne E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16:1996;2034-2043.
11. 2+ in vitro. NeuroReport. 5:1994;1063-1068.
12. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative diseases. Trends Pharmacol. Sci. 11:1990;379-387.
13. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
14. Orlando L.R., Standaert D.G., Penney J.B., Young A.B. Metabotropic receptors in excitotoxicity: (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG) protects against rat striatal quinolinic acid lesions. Neurosci. Lett. 202:1995;109-112.
15. Pin J.P., Duvoisin R. Neurotransmitter receptors I: the metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
16. 3H]norephinephrine release from rat hippocampal slices. J. Pharmacol. Exp. Ther. 266:1993;796-803.
17. Santi M.R., Wroblewska B., Neale J.H. NAAG acts through metabotropic glutamate receptors in cultured glial cells. Soc. Neurosci. Abstr. 21:1995;847.
18. Sekiguchi M., Wada K., Wenthold R.J. N-Acetyl-aspartylglutamate acts as an agonist upon homomeric NMDA receptor (NMDAR1) expressed in Xenopus oocytes. FEBS Lett. 311:1992;285-289.
19. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14:1994;3005-3018.
20. Trombley P.Q., Westbrook G.L. L-AP4 inhibits calcium currents and synaptic transmission via a G-protein-coupled glutamate receptor. J. Neurosci. 12:1992;2043-2050.
21. Valivullah, H.M., Lancaster, J., Sweetnam, P.M. and Neale, J.H., Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites, J. Neurochem., 63 (1994) 1714-1719.
22. Westbrook G.L., Mayer M.L., Nambooodiri M.A.A., Neale J.H. High concentrations of N-acetyl-aspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture. J. Neurosci. 6:1986;3385-3392.
23. Wroblewska B., Santi M.R., Neale J.H. NAAG activates cloned mGluR3 receptor. Soc. Neurosci. Abstr. 21:1995;847.
24. Wroblewska B., Wroblewski J.T., Saab O.H., Neale J.H. N-Acetylaspartyl-glutamate inhibits forskolin-stimulated cyclic AMP levels via a metabotropic glutamate receptor in cultured cerebellar granule cells. J. Neurochem. 61:1993;943-948.